Drug Topics

MAY 3, 2023

The vaccine is approved for use in adults aged 60 and older to prevent lower respiratory tract disease caused by RSV.

Vaccines 469

Vaccines FDA 469

PharmaVoice

MAY 3, 2023

The CEO of a Bay-area startup shares his strategies for growing a team from the ground up.

241

241

Drug Topics

MAY 3, 2023

According to a recent study, the association between employment status and contraceptive use observed in a period before the Affordable Care Act (ACA) was not found after the ACA ended.

247

247

STAT

MAY 3, 2023

If you flip to the 1,031st page of the May 1998 edition of the Journal of Cell Biology, you’ll find the first scientific byline for Daniel Skovronsky, then a young trainee at the University of Pennsylvania, on an article describing how beta-amyloid, a vexing molecule thought to play a role in Alzheimer’s disease, was more complicated than the field understood.

139

139

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Pharmacy Times

MAY 3, 2023

The advent of pharmacy-based community health workers has helped to expand and codify the pre-existing community-based efforts of pharmacy technicians to reach even outside of medication access.

132

132

PharmaVoice

MAY 3, 2023

Patil’s dual interests in healthcare and law are at the intersection of her C-suite role.

130

130

Fierce Healthcare

MAY 3, 2023

Telehealth providers cheer DEA move to temporarily extend virtual prescribing flexibilities hlandi Wed, 05/03/2023 - 15:16

128

128

Fierce Pharma

MAY 3, 2023

ImmunoGen touts 'home run' as ovarian cancer drug Elahere extends lives in landmark trial win aliu Wed, 05/03/2023 - 14:50

127

127

Fierce Healthcare

MAY 3, 2023

L.A.

126

126

Pharmacy Times

MAY 3, 2023

In addition to 2 FDA-approved options, several clinical trials are investigating other potential treatments for immunoglobulin A nephropathy.

FDA 123

FDA 123

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Fierce Healthcare

MAY 3, 2023

Hospital margins inch up in March as volume, revenue growth outpace expenses dmuoio Wed, 05/03/2023 - 12:39

Hospitals 122

Hospitals 122

European Pharmaceutical Review

MAY 3, 2023

The blood-brain barrier (BBB) in glioblastoma patients was opened temporarily using a novel, skull-implantable ultrasound device to deliver chemotherapy to the brain in a first in-human trial. Scientists at Northwestern Medicine in the US showed that opening the BBB led to an approximately four- to six-fold increase in drug concentrations in the human brain, results from the study found.

Chemotherapy 119

Chemotherapy 119

Fierce Healthcare

MAY 3, 2023

How a Medicare-X model could impact patients, hospitals: Urban Institute fdiamond Wed, 05/03/2023 - 16:40

Hospitals 118

Hospitals 118

STAT

MAY 3, 2023

A drug approved in November as the first new treatment for advanced ovarian cancer in over seven years has now been shown to extend patients’ lives, its developer, Immunogen, said Wednesday. Immunogen released data from a trial comparing the new drug, Elahere, to traditional chemotherapy in 453 ovarian cancer patients who had already progressed on at least one other therapy and had a particular protein marker on their tumor.

Chemotherapy 110

Chemotherapy 110

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Fierce Healthcare

MAY 3, 2023

Talkspace boosts 2023 outlook buoyed by strong growth in payer, employer business hlandi Wed, 05/03/2023 - 11:40

118

118

STAT

MAY 3, 2023

Akili Interactive on Wednesday revealed earlier-than-expected top-line clinical trial results suggesting its video game treatment for attention deficit hyperactivity disorder is effective for adults. That’s very good news for a company that’s racing to reach more patients in hopes of building a sustainable business.

110

110

Fierce Healthcare

MAY 3, 2023

Medicare Advantage enrollment officially crosses 50% of beneficiaries: KFF pminemyer Wed, 05/03/2023 - 14:12

116

116

STAT

MAY 3, 2023

Sun Microsystems co-founder Vinod Khosla is famous for predictions that have helped usher in the high tech world we live in today — and made him very wealthy in the process. On Wednesday, he made another bold forecast: A fully computerized doctor could be seeing patients before the decade is out. “Within 5 to 6 years, the FDA will approve a primary care app qualified to practice medicine like your primary care physician,” he said onstage at the STAT Breakthrough Summit

FDA 106

FDA 106

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

The Guardian - Pharmaceutical Industry

MAY 3, 2023

Donanemab is second drug in a year to succeed in trials in what could be ‘beginning of the end’ of disease A new Alzheimer’s drug slowed cognitive decline by 35%, according to late-stage trial results, raising the prospect of a second effective treatment for the disease. Donanemab met all goals of the trial and slowed progression of the condition by 35% to 36% compared with a placebo in 1,182 people with early-stage Alzheimer’s, the drugmaker Lilly said.

105

105

European Pharmaceutical Review

MAY 3, 2023

A market report has shown that the digital biomanufacturing market is anticipated to grow at a compound annual growth rate (CAGR) of 11 percent between 2023-2035, driven largely by digital transformation. Influencing factors identified in the report include higher competition, competitive pricing and inflation rate, technological advancements and evolving regulatory guidelines.

Compounding 105

Compounding 105

STAT

MAY 3, 2023

The Drug Enforcement Administration is holding off on making sweeping changes to the way certain drugs can be prescribed via telemedicine — for now. The DEA announced Wednesday that it was temporarily extending its Covid-era emergency telehealth policies, allowing doctors continued leniency in how they prescribe some controlled substances. The affected medications include buprenorphine, the most common medication used to treat opioid addiction, and stimulants like Adderall used to treat A

Controlled Substances 103

Controlled Substances 103

pharmaphorum

MAY 3, 2023

Otsuka’s lupus nephritis drug Lupkynis backed for NHS use Phil.

98

98

STAT

MAY 3, 2023

WASHINGTON – The tobacco giant RJ Reynolds is threatening to sue small vape shops if they do not stop selling flavored vapes, according to two letters obtained by STAT. The letters, both of which were sent in March, give the vape shops just a few days to confirm they will no longer sell flavored tobacco products. Failure to comply could result in “legal action, and the costs, attorneys’ fees, and adverse publicity to which a lawsuit would subject [the vape shop],” the

FDA 103

FDA 103

Pharmaceutical Technology

MAY 3, 2023

Since 2015, the US Food and Drug Administration (FDA) has approved more than 450 “first generics” or the first generic equivalent for a branded drug. These medicines comprise about 10% of all generics approved each year. First generics are the first opportunity manufacturers have to market new generic drug products in the US. In recent years, first generics have improved patient access to essential treatments and offered affordable treatment options for patients with multiple sclerosis, asthma,

FDA 98

FDA Generic Medicine Communication 98

STAT

MAY 3, 2023

Twenty years ago, CAR-T cell therapy was not quite “believed in,” said Michel Sadelain, director of the Center for Cellular Engineering at Memorial Sloan Kettering Cancer Center. It was hard to find patients to put in a trial, he said, because physicians were skeptical of the new technology. Then, when the first patients were successfully treated, there was “suddenly this turnabout, a tsunami as some would say, of young scientists and not-so-young scientists embracing this.

Immunization 101

Immunization 101

European Pharmaceutical Review

MAY 3, 2023

The European Commission (EC) has granted approval for Breyanzi (lisocabtagene maraleucel; liso-cel), a CD19-directed chimeric antigen receptor (CAR) T-cell therapy. The CAR T-cell therapy has a 4-1BB costimulatory domain which enhances the expansion and persistence of the CAR T cells. The treatment is indicated for adults with diffuse large B-cell lymphoma (DLBCL), high grade B-cell lymphoma (HGBCL), primary mediastinal large B-cell lymphoma (PMBCL) and follicular lymphoma grade 3B (FL3B) who re

Chemotherapy 98

Chemotherapy 98

STAT

MAY 3, 2023

The Food and Drug Administration on Wednesday licensed the first-ever vaccine for respiratory syncytial virus, or RSV , completing an elusive quest that has been decades in the making. The product, GSK’s Arexvy, was approved for adults ages 60 and older. GSK beat a crowded field of competitors to cross the finish line first. A vaccine that was developed by Pfizer and aimed at the same demographic is expected to be approved by the end of the month.

Vaccines 98

Vaccines FDA 98

The Checkup by Singlecare

MAY 3, 2023

Vitamin D is essential for keeping bones strong. This nutrient also contributes to healthy immune systems, muscle movement, and nerve function. Still, nearly 1 in 4 Americans experiences vitamin D deficiency. Though vitamin D can be increased through diet and sun exposure, some people need to take daily vitamin D supplements to correct low levels of this essential nutrient.

Immunization 98

Immunization Dosage Communication 98

STAT

MAY 3, 2023

The Food and Drug Administration approves dozens of cancer drugs every year, but the vast majority of them offer gradual improvements. A treatment might shrink tumors in a third of patients, or extend survival by a couple months, and a company can still haul in billions. The results were much more revolutionary when, at six years old, Emily Whitehead became the first child to receive CAR-T cell therapy, in which researchers arm a patient’s own immune cells against their cancer.

Immunization 98

Immunization 98

Drug Store News

MAY 3, 2023

Seven of the 10 best-performing states—Massachusetts, Rhode Island, Pennsylvania, New Jersey, Connecticut, New York and Vermont—were in the Northeast.

98

98

STAT

MAY 3, 2023

The U.S. is facing unprecedented  health care labor shortages  and related cost pressures. In the U.K., the National Health Service has witnessed its  largest nursing strike in history  alongside  junior doctor strikes , which have been prompted by staffing shortfalls and inadequate pay.  Europe is endangered  by an aging workforce, growing absenteeism, and health care workers simply quitting the field.

98

98

Hospital Pharmacy Europe

MAY 3, 2023

Inhaled isopropyl alcohol may represent a useful treatment for the emergency department management of patients with nausea and vomiting Nausea and vomiting were responsible for 1.6 million US emergency department (ED) visits in 2007. Current antiemetic drugs including ondansetron and metoclopramide are effective. Despite this, evidence to support the efficacy of one drug over any other is lacking.

Hospitals 98

Hospitals 98

STAT

MAY 3, 2023

When it comes to personal health information, many people are actually willing to share their data, according to Anne Wojcicki, co-founder and CEO of genetic testing company 23andMe. But the health care system has to start treating people less like test subjects, and more like people who want to contribute to medical research. “There needs to be more of that mindset: give people choice, give people transparency.

98

98